Kaine Welcomes Draft FDA Guidance to Improve Accelerated Approval Process for Lifesaving Drugs
December 06, 2024
December 06, 2024
WASHINGTON, Dec. 6 -- Sen. Tim Kaine, D-Virginia, issued the following news release:
Today, U.S. Senator Tim Kaine (D-VA), a member of the Help, Education, Labor, and Pensions Committee, released the following statement regarding the U.S. Food and Drug Administration's (FDA) issuance of draft guidance, in accordance with bipartisan legislation Senator Kaine championed, to provide clarity regarding the FDA's accelerated approval pathway, an important regulatory mechanism th . . .
Today, U.S. Senator Tim Kaine (D-VA), a member of the Help, Education, Labor, and Pensions Committee, released the following statement regarding the U.S. Food and Drug Administration's (FDA) issuance of draft guidance, in accordance with bipartisan legislation Senator Kaine championed, to provide clarity regarding the FDA's accelerated approval pathway, an important regulatory mechanism th . . .